- Effect of the selective norepinephrine reuptake inhibitor reboxetine on cognitive dysfunction in schizophrenia patients: an add-on, double-blind placebo-controlled study. Poyurovsky, M., Faragian, S., Fuchs, C., Pashinian, A. Isr. J. Psychiatry. Relat. Sci (2009)